These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 19625605)
61. Characterisation of human recombinant somatostatin receptors. 2. Modulation of GTPgammaS binding. Siehler S; Hoyer D Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):500-9. PubMed ID: 10598789 [TBL] [Abstract][Full Text] [Related]
62. Functional coupling between metabotropic glutamate receptors and G-proteins in rat cerebral cortex assessed by guanosine-5'-O-(3-[(35)S]thio)triphosphate binding assay. Odagaki Y; Kinoshita M; Toyoshima R Basic Clin Pharmacol Toxicol; 2011 Sep; 109(3):175-85. PubMed ID: 21443596 [TBL] [Abstract][Full Text] [Related]
63. Development of an immobilized GPR17 receptor stationary phase for binding determination using frontal affinity chromatography coupled to mass spectrometry. Temporini C; Ceruti S; Calleri E; Ferrario S; Moaddel R; Abbracchio MP; Massolini G Anal Biochem; 2009 Jan; 384(1):123-9. PubMed ID: 18835238 [TBL] [Abstract][Full Text] [Related]
64. Autoradiography of serotonin 5-HT1A receptor-activated G proteins in guinea pig brain sections by agonist-stimulated [35S]GTPgammaS binding. Dupuis DS; Palmier C; Colpaert FC; Pauwels PJ J Neurochem; 1998 Mar; 70(3):1258-68. PubMed ID: 9489749 [TBL] [Abstract][Full Text] [Related]
65. Somatostatin5 receptor-mediated [35S]guanosine-5'-O-(3-thio)triphosphate binding: agonist potencies and the influence of sodium chloride on intrinsic activity. Williams AJ; Michel AD; Feniuk W; Humphrey PP Mol Pharmacol; 1997 Jun; 51(6):1060-9. PubMed ID: 9187273 [TBL] [Abstract][Full Text] [Related]
66. Characterization of 5-HT1A receptor-mediated [35S]GTPgammaS binding in rat hippocampal membranes. Alper RH; Nelson DL Eur J Pharmacol; 1998 Feb; 343(2-3):303-12. PubMed ID: 9570480 [TBL] [Abstract][Full Text] [Related]
67. Autoradiographic studies of 5-HT1A-receptor-stimulated [35S]GTPgammaS-binding responses in the human and monkey brain. Dupuis DS; Pauwels PJ; Radu D; Hall H Eur J Neurosci; 1999 May; 11(5):1809-17. PubMed ID: 10215933 [TBL] [Abstract][Full Text] [Related]
68. Agonist and antagonist properties of antipsychotics at human dopamine D4.4 receptors: G-protein activation and K+ channel modulation in transfected cells. Newman-Tancredi A; Heusler P; Martel JC; Ormière AM; Leduc N; Cussac D Int J Neuropsychopharmacol; 2008 May; 11(3):293-307. PubMed ID: 17897483 [TBL] [Abstract][Full Text] [Related]
69. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding. Shaw JL; Gackenheimer SL; Gehlert DR J Chem Neuroanat; 2003 Nov; 26(3):179-93. PubMed ID: 14615027 [TBL] [Abstract][Full Text] [Related]
70. [35S]GTPgammaS binding at the human dopamine D4 receptor variants hD4.2, hD4.4 and hD4.7 following stimulation by dopamine, epinephrine and norepinephrine. Czermak C; Lehofer M; Liebmann PM; Traynor J Eur J Pharmacol; 2006 Feb; 531(1-3):20-4. PubMed ID: 16423344 [TBL] [Abstract][Full Text] [Related]
71. The [35S]GTPgammaS binding assay: approaches and applications in pharmacology. Harrison C; Traynor JR Life Sci; 2003 Dec; 74(4):489-508. PubMed ID: 14609727 [TBL] [Abstract][Full Text] [Related]
72. In vitro autoradiography of serotonin 5-HT(2A/2C) receptor-activated G protein: guanosine-5'-(gamma-[(35)S]thio)triphosphate binding in rat brain. Adlersberg M; Arango V; Hsiung S; Mann JJ; Underwood MD; Liu K; Kassir SA; Ruggiero DA; Tamir H J Neurosci Res; 2000 Sep; 61(6):674-85. PubMed ID: 10972964 [TBL] [Abstract][Full Text] [Related]
73. Characterization of endomorphin-1 and -2 on [35S]GTPgammaS binding in the mouse spinal cord. Narita M; Mizoguchi H; Oji GS; Tseng EL; Suganuma C; Nagase H; Tseng LF Eur J Pharmacol; 1998 Jun; 351(3):383-7. PubMed ID: 9721032 [TBL] [Abstract][Full Text] [Related]
74. Selective detection of adenosine A1 receptor-dependent G-protein activity in basal and stimulated conditions of rat brain [35S]guanosine 5'-(gamma-thio)triphosphate autoradiography. Laitinen JT Neuroscience; 1999; 90(4):1265-79. PubMed ID: 10338296 [TBL] [Abstract][Full Text] [Related]
75. Delta opioid modulation of the binding of guanosine-5'-O-(3-[35S]thio)triphosphate to NG108-15 cell membranes: characterization of agonist and inverse agonist effects. Szekeres PG; Traynor JR J Pharmacol Exp Ther; 1997 Dec; 283(3):1276-84. PubMed ID: 9400003 [TBL] [Abstract][Full Text] [Related]
76. Molecular cloning, pharmacological properties and tissue distribution of the porcine 5-HT(1B) receptor. Bhalla P; Sharma HS; Ma X; Wurch T; Pauwels PJ; Saxena PR Br J Pharmacol; 2001 Jul; 133(6):891-901. PubMed ID: 11454663 [TBL] [Abstract][Full Text] [Related]
77. [Role of G protein-coupled receptor 17 in central nervous system injury]. Zhang Z; Wei E; Lu Y Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 May; 42(3):355-9. PubMed ID: 23801627 [TBL] [Abstract][Full Text] [Related]
78. Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. von Kügelgen I Pharmacol Ther; 2006 Jun; 110(3):415-32. PubMed ID: 16257449 [TBL] [Abstract][Full Text] [Related]
79. Effects of an agonist, allosteric modulator, and antagonist on guanosine-gamma-[35S]thiotriphosphate binding to liposomes with varying muscarinic receptor/Go protein stoichiometry. Jakubík J; Haga T; Tucek S Mol Pharmacol; 1998 Nov; 54(5):899-906. PubMed ID: 9804625 [TBL] [Abstract][Full Text] [Related]
80. A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights. Parravicini C; Daniele S; Palazzolo L; Trincavelli ML; Martini C; Zaratin P; Primi R; Coppolino G; Gianazza E; Abbracchio MP; Eberini I Cell Signal; 2016 Jun; 28(6):631-42. PubMed ID: 26971834 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]